CATEGORY : Diagnostics Market

Life Science Market Reports

Our life science market intelligence products have been recognized by market insiders and outsiders alike for their accuracy, in-depth analysis, and unique insights.

Market Reports

Emmes Data Insights: Supply-Chain Constraints Hinder Diagnostic Testing Capabilities

  Months into the COVID-19 pandemic, U.S. testing capacity continues to lag behind its goals. The Harvard Global Institute estimated that the U.S should have at least 900,000 SARS-CoV-2 tests

Emmes Data Insights: Hospital Labs’ Readiness for the Coronavirus Testing Onslaught

  SARS-CoV-2 media attention has largely focused on diagnostic reference labs as they have scaled up testing capacity. However, hospital labs, which drive the vast majority of seasonal respiratory virus

2020 Vision: 3 Recent Advancements in Computer Vision for Health

  The advent of computer vision – deep learning models trained on image data to classify, annotate, or otherwise characterize new images – offers a powerful toolkit for analyzing medical

Collaborative, Decentralized Research Drives Liquid Biopsy Advances – AGBT 2020

  For AGBT 2020, we analyzed collaboration networks within liquid biopsy publications to understand the landscape. We analyzed ~2,600 liquid biopsy publications 1, indexing ~1,300 affiliations and ~15,000 authors in 60

Supplying the COVID Demand — How Dx Behemoths and Tele-Diagnostics Entrants Aim to Close the Gap

  As more COVID-19 diagnostics win FDA emergency use authorization, weekly commercial production capacity is expected to hit 6.5M+ tests; telehealth providers attempt to jump into the fray, but are

A 2020 Look at 3 Trends in Immuno-Oncology Biomarkers

We recently added >300 new trials to our I/O biomarker clinical trial tracker, The I/O BioMAP, bringing our running total to ~2,700 studies, and providing new data that sheds light

How KKR Made a ~3x Return in 4 Years by Investing in Research Tools

  KKR made headlines late last year with the exit of their investment in LGC Group, a UK-based biochemical standards and reagents provider. Sources say KKR acquired LGC in December

Going Viral: What the COVID-19 Outbreak Teaches Us About the Evolution of the Biotech Industry

  The novel coronavirus (COVID-19) outbreak has been a huge topic of concern across the globe as infection and death tolls continue to grow daily. However, it’s inarguable that the

3 Takeaways for Digital Health from #CES2020

Consumer health techs hone clinical value propositions Criticism of the digital health space has largely centered on the lack of clinical utility and validity as a result of technologies built